In addition, a marked activation of the innate immune system was demonstrated and specific pro-inflammatory cytokines (e.g., IL-1 and IL-6) contribute to the multisystem inflammation and may ultimately lead to 5–8% of patients having the most severe complication of sJIA, the macrophage activation syndrome (MAS) (8). The gene discussed is IL6; the disease is macrophage activation syndrome.